Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Rising Prevalence of Diabetes Fueling Expansion of Global Transdermal Drug Delivery Systems MarketThe transdermal drug delivery systems market is projected to grow from just over $30.0 billion in 2016, to more than $60.0 billion in size by 2023, at a CAGR of 9.8% during 2017–2023 (forecast period).
By: P&S Intelligence Receive Sample Copy of this Report: https://www.psmarketresearch.com/ The increasing occurrence rate of diabetes is one of the major factors fueling the advancement of the market across the globe. As per the International Diabetes Federation (IDF), nearly 425 million people all over the world in the age bracket 20–79 years were diagnosed with diabetes in 2017 and this number is predicted to rise to 629 million by 2045. Apart from the growing incidence of chronic diseases, the surging geriatric population is also fueling the market expansion. Make an Enquiry before Purchase: https://www.psmarketresearch.com/ Geographically, the transdermal drug delivery systems market (https://www.psmarketresearch.com/ Hence, it can be said with full confidence that the market will register huge growth across the world in the coming years, primarily because of the growing incidence of chronic diseases such as diabetes, the rapidly increasing geriatric population, and the soaring healthcare expenditure in several countries. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|